Salivary Cortisol Response After Ropivacaine–Dexamethasone Administration: A Randomized Clinical Trial
Pharmaceuticals · 12.06.2026 · 19 (6) · 930
DOI: 10.3390/ph19060930 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Pharmaceuticals, online erschienen am 12.06.2026. Verfasst von Simona M Stojanović und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Surgery, Clinic for Dental Medicine, Faculty of Medicine, University of Niš, 18108 Niš, Serbia. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Science and Technological Development, University of Nis, Ministry of Education, Science and Technological Development of the Republic of Serbia.
Abstract (Originalsprache)
Background
This randomized parallel-group clinical study evaluated salivary cortisol as a biomarker of perioperative stress response during surgical extraction of impacted mandibular third molars performed under local anesthesia administration of ropivacaine and dexamethasone.
Methods
The trial was registered in the ISRCTN registry (ISRCTN87752106). Ninety patients undergoing impacted mandibular third molar surgery were randomly assigned (1:1:1; n = 30/group) to receive inferior alveolar nerve block with 0.5% ropivacaine plus dexamethasone (R+D group), 0.5% ropivacaine (R group), or 0.5% bupivacaine (B group). Salivary cortisol as the primary outcome was measured at 15 min before anesthesia, and 15 min and 24 h postoperatively. Preoperative psychological stress was assessed using the Revised Norman Corah Dental Anxiety Scale.
Results
No significant differences were observed between groups in preoperative anxiety (p = 0.890) or baseline salivary cortisol levels (p = 0.984). Significant intergroup differences in cortisol levels were observed at 15 min (p = 0.002) and 24 h postoperatively (p = 0.001). Cortisol levels at 15 min postoperatively were significantly lower in the R+D group compared to the R (p = 0.001) and B groups (p = 0.004) and after 24 h (R+D vs. R: p = 0.005; R+D vs. B: p < 0.001).
Conclusions
The ropivacaine–dexamethasone administration significantly reduced perioperative salivary cortisol levels compared to ropivacaine alone or bupivacaine alone during impacted mandibular third molar surgery. This modulation of the neuroendocrine response likely results from dexamethasone-induced suppression of hypothalamic–pituitary–adrenal axis and the improved analgesic effects of this combination. The observed results may contribute to improved physiological stability, postoperative recovery and the clinical benefit of this anesthetic approach in oral surgery.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oral Surgery, Clinic for Dental Medicine, Faculty of Medicine, University of Niš, 18108 Niš, Serbia.
- Department of Immunology, Faculty of Medicine, University of Niš, 18108 Niš, Serbia.
- Department of Oral Surgery, Faculty of Medicine, University of Niš, 18108 Niš, Serbia.
- Department of Preventive and Pediatric Dentistry, Clinic for Dental Medicine, Faculty of Medicine, University of Niš, 18108 Niš, Serbia.
- Department of Maxillofacial Surgery, Clinic for Dental Medicine, Faculty of Medicine, University of Niš, 18108 Niš, Serbia.
- Department of Oral Medicine and Periodontology, Faculty of Medicine, University of Niš, 18108 Niš, Serbia.
ORCID-Profile: Branislava B Stojković, Miloš Tijanić
Förderung
- Ministry of Education, Science and Technological Development
- University of Nis
- Ministry of Education, Science and Technological Development of the Republic of Serbia
Zitieren
APA
Stojanović, S. M., Burić, N. B., Kostić, M. S., Burić, K. N., Stojković, B. B., Spasić, M. S., Tijanić, M., Trajković, M., Jovanović, R., & Petrović, M. S. (2026). Salivary Cortisol Response After Ropivacaine–Dexamethasone Administration: A Randomized Clinical Trial. Pharmaceuticals, 19(6), 930. https://doi.org/10.3390/ph19060930
Vancouver
Stojanović SM, Burić NB, Kostić MS, Burić KN, Stojković BB, Spasić MS, et al. Salivary Cortisol Response After Ropivacaine–Dexamethasone Administration: A Randomized Clinical Trial. Pharmaceuticals. 2026;19(6):930. doi:10.3390/ph19060930
BibTeX
@article{Stojanovi2026,
author = {Stojanović, Simona M and Burić, Nikola B and Kostić, Miloš S and Burić, Kristina N and Stojković, Branislava B and Spasić, Milan S and Tijanić, Miloš and Trajković, Miloš and Jovanović, Rodoljub and Petrović, Milica S},
title = {Salivary Cortisol Response After Ropivacaine–Dexamethasone Administration: A Randomized Clinical Trial},
journal = {Pharmaceuticals},
year = {2026},
volume = {19},
number = {6},
pages = {930},
doi = {10.3390/ph19060930}
}
EUVIMED